Log In
BCIQ
Print this Print this
 

RP-G28

  Manage Alerts
Collapse Summary General Information
Company Ritter Pharmaceuticals Inc.
DescriptionShort chain oligosaccharide used to stimulate colonic growth of lactose-fermenting bacteria in the large intestine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II/III
Standard Indication Gastrointestinal (unspecified)
Indication DetailsTreat lactose intolerance
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today